Search - tctmd.com

Displaying 361 - 380 of 511

Sort: Relevancy | Date

Presentation TCT 2014

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Mark H. Wholey

September 14, 2014

Presentation TCT 2014

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Raghu Kolluri

September 14, 2014

Presentation TCT 2014

The BEST and BASIL 2 Studies: Designs and Goals

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Kenneth Rosenfield

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

Presentation TCT 2014

A Primer of the Pedal Circulation: Relevance to Revascularization Strategies

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Jihad A. Mustapha

September 14, 2014

Presentation TCT 2014

Is Arteriopathy Below the Knee Biologically Unique? Implications for Therapeutic Approaches

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Lanfroi Graziani

September 14, 2014

Presentation TCT 2014

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Mahmood K. Razavi

September 13, 2014

Presentation TCT 2014

Calcification in Femoropopliteal Intervention: Management Options and Outcomes

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, D. Christopher Metzger

September 13, 2014

Presentation TCT 2014

Endovascular Approaches to Common Femoral Artery Obstructive Disease: Finally Ready for Primetime?

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Thomas Zeller

September 13, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

Presentation

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Presenter: Francesco Liistro

February 24, 2014

News Daily News

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

L.A. McKeown

January 20, 2014

Presentation

SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

Presenter: Michael R. Jaff

January 20, 2014

Presentation

Is There a True Role for Endovascular Intervention for Below-Knee PAD?

Presenter: William A. Gray

December 01, 2013

Presentation TCT 2013

Role of Wound Perfusion Assessment in the Management of CLI

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

Postinterventional Hyperemic Edema: Managing a Frequent Remnant of the Successful CLI Intervention

Presenter: James Joye

October 28, 2013

Presentation TCT 2013

Nonsense: Get It Open, Heal the Wound, and Move On!

Presenter: Gary Ansel

October 28, 2013

Advertisement

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

The BEST and BASIL 2 Studies: Designs and Goals

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

A Primer of the Pedal Circulation: Relevance to Revascularization Strategies

Is Arteriopathy Below the Knee Biologically Unique? Implications for Therapeutic Approaches

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Calcification in Femoropopliteal Intervention: Management Options and Outcomes

Endovascular Approaches to Common Femoral Artery Obstructive Disease: Finally Ready for Primetime?

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

Is There a True Role for Endovascular Intervention for Below-Knee PAD?

Role of Wound Perfusion Assessment in the Management of CLI

Postinterventional Hyperemic Edema: Managing a Frequent Remnant of the Successful CLI Intervention

Nonsense: Get It Open, Heal the Wound, and Move On!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content